|
Volumn 213, Issue 4, 2001, Pages 162-168
|
Improved results in the treatment of acute myeloid leukemia - Results of study AML-BFM-93 in east germany with comparisons to the preceding studies AML-I-82 and AML-II-87;Verbesserte Ergebnisse in der Therapie der akuten myeloischen Leukämie - Ergebnisse der Therapie-studie AML-BFM-93 in den neuen Bundesländern im Vergleich mit den Vorgängerstudien AML-I/82 und AML-II/87 der DDR
a b c b d b e f g b b h b a a,i,j i,j i,j i,j |
Author keywords
Acute myeloid leukaemia; Multicenter study; Prognosis; Toxicity
|
Indexed keywords
ANTILEUKEMIC AGENT;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
METHOTREXATE;
PREDNISOLONE;
TIOGUANINE;
VINCRISTINE;
ACUTE GRANULOCYTIC LEUKEMIA;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CARDIOTOXICITY;
CHILD;
CHILDHOOD LEUKEMIA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
INTERMETHOD COMPARISON;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NEPHROTOXICITY;
NEUROTOXICITY;
PRACTICE GUIDELINE;
SKIN TOXICITY;
TREATMENT OUTCOME;
ACUTE DISEASE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHILD;
CHILD, PRESCHOOL;
CLINICAL PROTOCOLS;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
GERMANY, EAST;
HUMANS;
INFANT;
INFANT, NEWBORN;
LEUKEMIA, MYELOID;
MALE;
RECURRENCE;
REMISSION INDUCTION;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 17944368391
PISSN: 03008630
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2001-16847 Document Type: Article |
Times cited : (6)
|
References (14)
|